1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYLBENZYLOXYIMINO)ETHYL]-2-ETHYL BENZYL]AZETIDINE-3-CARBOXYLIC ACID HEMIFUMARATE SALT

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]ethyl}-2-ethyl benzyl)azetidine-3-carboxylic acid hemifumarate salt, as well as to its polymorphous forms, pharmaceutical compositions inhibiting EDG receptors containing the above...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	RIKARDO SHNEBERGER, MEHRILIN DE-LA-KRUS, KASPAR FOGEL, LEKH TSIZHEVSKI, P'OTR KH. KARPINSKI, MIKHAEHL' MUTTS, KRISTIAN RIGER
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!